Page last updated: 2024-11-02

pargyline and Congenital Hypothyroidism

pargyline has been researched along with Congenital Hypothyroidism in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Congenital Hypothyroidism: A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA.

Research Excerpts

ExcerptRelevanceReference
" neonatal hyperthyroidism, produced by daily administration of L-triiodothyronine from birth, had no effect on the ontogenic patterns of serotonin."3.65Thyroid hormone control of serotonin in developing rat brain. ( Keesey, RR; Schwark, WS, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwark, WS1
Keesey, RR1

Other Studies

1 other study available for pargyline and Congenital Hypothyroidism

ArticleYear
Thyroid hormone control of serotonin in developing rat brain.
    Research communications in chemical pathology and pharmacology, 1975, Volume: 10, Issue:1

    Topics: Animals; Animals, Newborn; Basal Ganglia; Brain; Brain Stem; Congenital Hypothyroidism; Hyperthyroid

1975